These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1903366

  • 1. Progression of sugar cataract in the dog.
    Sato S, Takahashi Y, Wyman M, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S, Mori K, Wyman M, Kador PF.
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [Abstract] [Full Text] [Related]

  • 3. Age-dependent lens changes in galactose-fed dogs.
    Lackner PA, Rodriguez L, Sato S, Lizak MJ, Wyman M, Kador PF.
    Exp Eye Res; 1997 Mar; 64(3):431-6. PubMed ID: 9196395
    [Abstract] [Full Text] [Related]

  • 4. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

  • 5. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M, Fukui H, Kuwabara T, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [Abstract] [Full Text] [Related]

  • 6. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF, Betts D, Wyman M, Blessing K, Randazzo J.
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [Abstract] [Full Text] [Related]

  • 7. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV, Takahashi Y, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ, Tsui JY, Johnson MJ.
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ, Tsui JY.
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS, Kim J, Lee YM, Sohn E, Jo K, Kim JS.
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [Abstract] [Full Text] [Related]

  • 14. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Sato S, Wyman M.
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [Abstract] [Full Text] [Related]

  • 15. Galactose-induced cataract formation in guinea pigs: morphologic changes and accumulation of galactitol.
    Mackic JB, Ross-Cisneros FN, McComb JG, Bekhor I, Weiss MH, Kannan R, Zlokovic BV.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):804-10. PubMed ID: 8125742
    [Abstract] [Full Text] [Related]

  • 16. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [Abstract] [Full Text] [Related]

  • 17. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG, Laver NM, Jacot JL, Glover JP.
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantitation of galactosemic cataracts in dogs using magnetization transfer contrast-enhanced magnetic resonance imaging.
    Lizak MJ, Mori K, Ceckler TL, Balaban RS, Kador PF.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2219-27. PubMed ID: 8843908
    [Abstract] [Full Text] [Related]

  • 20. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.